206 related articles for article (PubMed ID: 24403858)
1. N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.
Armstrong MB; Mody RJ; Ellis DC; Hill AB; Erichsen DA; Wechsler DS
Neoplasia; 2013 Dec; 15(12):1363-70. PubMed ID: 24403858
[TBL] [Abstract][Full Text] [Related]
2. Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas.
Engstrom LD; Youkilis AS; Gorelick JL; Zheng D; Ackley V; Petroff CA; Benson LQ; Coon MR; Zhu X; Hanash SM; Wechsler DS
Neoplasia; 2004; 6(5):660-73. PubMed ID: 15548375
[TBL] [Abstract][Full Text] [Related]
3. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
[TBL] [Abstract][Full Text] [Related]
5. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
6. p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.
Horvilleur E; Bauer M; Goldschneider D; Mergui X; de la Motte A; Bénard J; Douc-Rasy S; Cappellen D
Nucleic Acids Res; 2008 Aug; 36(13):4222-32. PubMed ID: 18583365
[TBL] [Abstract][Full Text] [Related]
7. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
Slack A; Chen Z; Tonelli R; Pule M; Hunt L; Pession A; Shohet JM
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):731-6. PubMed ID: 15644444
[TBL] [Abstract][Full Text] [Related]
8. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
[TBL] [Abstract][Full Text] [Related]
10. Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastoma.
Erichsen DA; Armstrong MB; Wechsler DS
Transl Oncol; 2015 Feb; 8(1):65-74. PubMed ID: 25749179
[TBL] [Abstract][Full Text] [Related]
11. p53 is a direct transcriptional target of MYCN in neuroblastoma.
Chen L; Iraci N; Gherardi S; Gamble LD; Wood KM; Perini G; Lunec J; Tweddle DA
Cancer Res; 2010 Feb; 70(4):1377-88. PubMed ID: 20145147
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
13. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
[TBL] [Abstract][Full Text] [Related]
14. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Mxi1-SRalpha and Mxi1-SRbeta in Myc antagonism.
Dugast-Darzacq C; Grange T; Schreiber-Agus NB
FEBS J; 2007 Sep; 274(17):4643-53. PubMed ID: 17697116
[TBL] [Abstract][Full Text] [Related]
16. MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma.
Lu F; Mu B; Jin G; Zhu L; Mu P
Oncol Res; 2022 May; 29(1):1-10. PubMed ID: 34937609
[TBL] [Abstract][Full Text] [Related]
17. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S
Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555
[TBL] [Abstract][Full Text] [Related]
18. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
19. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
Manohar CF; Bray JA; Salwen HR; Madafiglio J; Cheng A; Flemming C; Marshall GM; Norris MD; Haber M; Cohn SL
Oncogene; 2004 Jan; 23(3):753-62. PubMed ID: 14737110
[TBL] [Abstract][Full Text] [Related]
20. Change of MAX interactor 1 expression in an anti-Thy1 nephritis model and its effect on mesangial cell proliferation.
Liu X; Lv Y; Xie Y; Hong Q; Cai G; Zhang S; Liu W; Chen X
Cell Physiol Biochem; 2011; 27(3-4):391-400. PubMed ID: 21471728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]